Explore our active clinical trials below, highlighting the innovative research opportunities aimed at advancing cardiovascular care and improving patient outcomes.
Heart Failure ▾
-
Alleviant ALLAY-HF Study
-
Alleviant ALLAY-HFrEF Study
-
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) (FASTR-II)
-
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III (PROACTIVE-HF)
Hypertrophic Cardiomyopathy ▾
-
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy (SONATA-HCM)
Amyloid ▾
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)
-
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
-
eMyosoundNCT: —
-
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Interventional Cardiology ▾
-
Pulmonary Embolism – Thrombus Removal With Catheter-Directed Therapy (PE-TRACT)
-
ELEVATE High-Risk PCI Pivotal Study (ELEVATE III)
Myocarditis ▾
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis (ATRIUM)
Electrophysiology ▾
-
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation (REACT-AF)
-
Body Surface MappingNCT: —
-
Anodal Biphasic PacingNCT: —
Cardiac Nuclear Medicine ▾
-
Safer3NCT: —